Manufacturer
BAYER AG
Contents
Hydroxyprogesterone caproate
Indication
Recurrent miscarriage, Palliative treatment of advanced, inoperable endometrial carcinoma, Abnormal uterine bleeding, Amenorrhoea.
Instruction
Administer via Intramuscular
Drug interaction
Increased clearance when used with enzyme inducers e.g. carbamazepine and phenytoin. May inhibit metabolism of ciclosporin.
Malaysia
